Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript INO earnings call for the period ending September 30, 2024.…
Inovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript INO earnings call for the period ending June 30, 2024.…
Global Bipolar Disorder Market Size To Exceed USD 6.47 Billion By 2033 | CAGR Of 1.98% The Global Bipolar Disorder Market Size was Valued at USD 5.32 Billion in 2023, the Worldwide Bipolar Disorder Market Size…
Better Buy: Inovio Pharmaceuticals vs. Novavax Both biotechs have been struggling for a while, but there might be some hope for them.…
Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 2nd Annual BioConnect Investor Conference (Transcript) …
Global Oral Transmucosal Drugs Market Size To Exceed USD 62.3 Billion By 2033 | CAGR Of 6.5% The Global Oral Transmucosal Drugs Market Size was Valued at USD 33.2 Billion in 2023 and the Worldwide Oral Transmucosal…
Inovio Pharmaceuticals, Inc. (INO) Presents at 2024 RBC Capital Markets Global Healthcare Conference (Transcript) …
Oppenheimer maintains price target on Inovio Pharmaceuticals stock By Investing.com Oppenheimer maintains price target on Inovio Pharmaceuticals stock…
Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript INO earnings call for the period ending March 31, 2024.…
Ausblick: Inovio Pharmaceuticals öffnet die Bücher zum abgelaufenen Quartal Inovio Pharmaceuticals wird am 13.05.2024 das Zahlenwerk zum am 31.03.2024 abgelaufenen Jahresviertel vorstellen.In Sachen EPS gehen 5 Analysten von einem…
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript INO earnings call for the period ending December 31, 2023.…